Vasculitis and Giant Cell Arteritis
Clinical research is centered on giant cell arteritis, with attention to inflammatory disease activity, vascular involvement, and sustained remission in affected patients.
- Large-vessel inflammation
- Arterial vasculitis
- Remission maintenance
The sponsor’s current therapeutic interest is focused on immune-mediated control of vasculitic disease.
Immune Modulation
Research activity includes evaluation of abatacept in the context of immune checkpoint-related regulation of T-cell activation for inflammatory vascular disease.
- CTLA4-Ig
- T-cell costimulation
- Adaptive immunity
This area reflects interest in targeted immunotherapy for controlling pathogenic immune responses.
Rheumatology
The sponsor’s funded work aligns with rheumatologic disease research, particularly disorders characterized by systemic inflammation and vascular complications.
- Systemic inflammatory disease
- Autoimmune disease
- Clinical remission
Its research portfolio includes therapeutic interest in conditions managed within rheumatology and inflammatory medicine.
